chrisvoncsefalvay/vaers-outcomes huggingface dataset:
my heart beating fast/the pulse reading 170; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female patient received first dose bnt162b2 (PFIZER COVID 19 VACCINE, Lot number unknown), via an unspecified route of administration in the right arm on 05Feb2021 15:00 at SINGLE DOSE for covid-19 immunisation.  Medical history included arthritis and Penicillin Allergies.  The patient was not pregnant. The patient did not receive other vaccine on the same date and in four weeks. The patient's concomitant medications were unspecified other medication in two weeks.  Yesterday (05Feb2021) the patient received her first dose of Covid-19 vaccine at (vaccine facility name) around 3PM. They had everyone wait in the observation room for 15 minutes after the shot. She was fine during that time. In the evening around 8PM she noticed that her heart beating fast. A home use Oximeter showed the pulse reading 170 around 10PM. An hour later it went down to 105. This morning it came down to 84. She slept well last night. Her next appointment for the second dose is on 26Feb2021. Ae resulted in [None of the above]. The patient did not receive treatment for adverse event. The patient did not have COVID prior vaccination. The patient did not have COVID tested post vaccination. This event was non-serious and did not result in death and cause/prolong hospitalization, was not life threatening, Disabling/Incapacitating, Congenital anomaly/birth defect. Facility type Vaccine was Hospital.  The outcome of the event was recovered on 06Feb2021.  Information on the lot/batch number has been requested.
Night sweats; soreness at injection site; light headed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Apr2022 at 11:30 as dose 4 (booster), single (Lot number: fl3197) at the age of 51 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN]; TYLENOL. Vaccination history included: Covid-19 vaccine (Dose 1, primary series immunization completed but manufactured name unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 2, primary series immunization completed but manufactured name unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 3, Manufactured name unknown), for COVID-19 Immunization. The following information was reported: NIGHT SWEATS (non-serious) with onset 14Apr2022 at 22:00, outcome "recovering"; DIZZINESS (non-serious) with onset 14Apr2022 at 22:00, outcome "recovering", described as "light headed"; VACCINATION SITE PAIN (non-serious) with onset 14Apr2022 at 22:00, outcome "recovering", described as "soreness at injection site". Therapeutic measures were not taken as a result of night sweats, vaccination site pain, dizziness.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Advil, Tylenol within 2 weeks of vaccination. The patient was not tested since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no known allergies.
about 3 days p/vax pt exp gen ill feeling & pus in urine;urine cleared, ill feeling lasted approx 7-10 days w/nervousness & eating disorder exp;tx for sinus congestion;felt ill & sick;pus in urine;sleeping & eating diff;jerky & trembly;numb
This case was reported by a physician via call center representative and described the occurrence of dyskinesia in a 6-month-old female patient who received PEDIARIX (batch number M9L74, expiry date 18th November 2018). Concomitant products included PEDVAXHIB, PREVNAR and ROTATEQ. On 21st February 2017 17:00, the patient received the 3rd dose of PEDIARIX (intramuscular) .5 ml. On 21st February 2017, several hours after receiving PEDIARIX, the patient experienced dyskinesia (serious criteria hospitalization and other: As per reporter). On an unknown date, the outcome of the dyskinesia was unknown. It was unknown if the reporter considered the dyskinesia to be related to PEDIARIX. Additional details were provided as follows: The patient had no known allergies and no medically significant medical history. The patient had symptoms of seizure like disorder a few hours after the vaccines. The patient was taken to the emergency room and was admitted. She was evaluated by a neurologist in the hospital who diagnosed her with benign paroxysmal movement disorder, per reporting physician. On 2nd March 2017, the patient was discharged from the hospital. The reported batch number for PEDIARIX (M91L74) did not exist and was updated to M9L74 as per sales data sheet.
Employee received Varivax #1 12/1/06 along with Hep B #3 and MMR #1.  He reported to EH on 12/21/06 with vesicles on trunk, arms, neck, and head that he states started appearing on 12/18/06.  He states they worsened each day.
pt reported numbness, tingling, cramping to back of calf muscle and discoloration  dots on feet (smaller than pencil eraser)
Within 5 min of vaccines pt was pale, decreased tone, poor feeding. Symptoms started to improve after approximately 10 hours. Event consistent with HHE.
Eight days after receiving my vaccine, I woke up and noticed a raised rash on my arm. About 8-9 hours later, I was about to take a shower and it was about the size of a quarter. It was really red & hot. I woke up the next morning, and it was the size of a plum, maybe an orange. I decided to go to the dr. and they had no clue what was going on. They put me on antibiotics. I stopped taking them because I felt like I didn't need them. While I was at the dr, they did a thermal temperature scan. The thermal temperature was 101.7.
Arm where injected-so sore-went to bed at 3pm-got up at 5pm. Arm swollen and red from shoulder to elbow. Developed itching and hives on arm. Could not lift arm above chest. Slowly got better. Took one week.
Seconds after vac pt c/o dizziness "feels funny" sweaty, felt faint (+) nausea - momentarily unresponsive verbally - clonic movement all kept drawing toward mid abdomen - No seizure activity, or incontinence - No tongue biting - 911 called.
Large local reaction with lymphangitic spread to axilla (12 x 15 cm) and suspected secondary bacterial cellulitis with fever to 100 and chest wall pain (costochonditis) occurring 9-10 days post vax. Treated with NSAIDs, Keflex, Benadryl.
On June 26, 1999, the pt received his first treatment with Lymerix. Two weeks later he experienced pain in his left knee "gimpy knee" and a burning sensation in his left calf.  The most recent information received on 6/28/99, reports the knee pain resolved, and the burning calf sensation resolved. The pt received the second Lymerix dose and he did not report any adverse events, "all ok".
Appearance of a very red, edematous, warm 5 cm area where vaccine was given. Pt responded to course of antihistamine and mupirocin.
Fever of 102.3-104 at one point. Staying about 103 now. Hot and cold sweats
Erythematous papules starting mid chest in one dermatome around left chest extending to mid axillary line. Veteran not aware of erythematous rash in mid axillary line-states it is new since he left his home. No vesicle noted. No pustules, no other vesicles. Rash, onset and localized to single dermatome suggestive of mild herpes zoster. Assessment/Impression: ? mild herpes zoster. Valacyclovir 1 gm TID.
2/20/21-Arrived at ER, with complaints of SOB, weakness and productive cough. Hx of COPD, baseline o2 Sat 92-94% on 2L o2 via NC, o2 sat today at home 88-90%. Positive home COVID test x 2.  86% o2 sat placed on 4LNC, RR-17, HR 90, 100.04 oral temp. Covid+ test on admission. Admit with Acute Hypoxic distress secondary to Covid Pneumonia CXR showed bi basilar atelectasis or infiltrates. IV Azithromycin, IV Decadron, IV Remdesivir, DuoNeb, baricitinib , Elliquis and acetaminophen  started. 2/21/21- Patient continues on 4LNC o2 sat 92%, states SOB and coughing improving. Afebrile. Supplemental 02 continued will try to to taper off to his home o2 level (2.5L), Continue on IV remdesivir, dexamethasone  2/21/21- dexamethasone and baricitinib. Will continue home inhalers ordered, Dulera instead of Symbicort, Albuterol as needed, Spiriva instead of Ellipta and Combivent instead of DuoNeb. 2/22/21-Patient currently requiring his baseline oxygen, 2.5L sat 92%. Stop remdesivir and discharged to  home, resume  home medications.
c/o headache, fatigue, muscle pain / chest pain that did not allow sleep last night. No redness at injection site. 24 hrs after shot has severe muscle pain / headache / malaise. Tylenol 1000mg given PO in office.
he receved vaccination on a friday and had a high fever from friday until Monday morning. He was staring into space body limp no reaction.doctor concluded he had seizures caused from the vaccinations.  9/21/09 Hospital records received DOS 8/3/09 to 8/5/09. Assessment: Febrile seizure secondary to vaccination. Patient presented with fever, unresponsive episode, drooling, "breathing hard', hot, temp 104. Postictal or near end of seizure. Right arm flexed, listless, staring. Admitted for evaluation of fever and possible seizure.  ICD9: 780.31, E949.6
Patient experienced low grade fever and fatigue.  Parents managed with fever/pain reliever and rest.  Symptoms resolved without complication after 2 days.
Received vaccine at Covid-19 pop-up clinic on 4/5/21 at 2:30pm. Was fine during the vaccine administration. Waited 30 minutes after vaccination and left the clinic and felt fine. About 15-30 minutes later she was driving around running errands and was drinking water in the car and she noticed that it was becoming hard to swallow. Felt dizzy and disoriented and called her allergist. She carries epi pen because she gets allergy shots due to dog and cat allergies. Epi pen is for potential reaction to allergy shot. Allergist advised her to call EMS. She called EMS and they told her to administer the epi pen. She administered epi pen and began to feel symptoms improve. EMS arrived and she felt better and was not transported to the hospital. She drove herself home and was fine the rest of the day. She also had a topical reaction to the band-aid on her arm, with blisters and ripping off her skin. She generally has allergy issues with adhesives.
PT ADVISED THAT SHE HAD ANAPHYLACTIC RXN TO FIRST DOSE AND WAS UNABLE TO GET SECOND DOSE
Vasovagal syncope immediately after IM injection.  Lowered pt to floor and elevated LE on chair.  Pt responsive and AOx4.  Taken to Med Obs 1 for VS, assessment and further observation.  VS WNL and no reported or objective s/s distress noted during assessment.  Pt reported symptoms resolved and escorted to doors from Med Obs 1 at approx 0848 VS Sitting 0832 BP 108/67  HR 83  RR 16  SpO2 98% RA  Sitting 0845 BP 113/58  HR 76  RR 16  SpO2 98% RA Standing 0846 BP 1108/62  HR 74  RR 16  SpO2 100% RA
This spontaneous medically confirmed report (initial receipt 24-Nov-2014) concerns a 40-year-old patient. On 24-Nov-2014, the patient received intramuscular AFLURIA (batch number not reported) at a dose of 1 ml. No adverse reactions occurred since administration. Outcome was reported as recovered. Reporter's comments: The reporter assessed the event as non-serious.
Injection site,Rt arm developed redness/swelling & itchiness 1 week after Injection
Very red, swollen, painful, hot and itches. The swollen area is 4 inches long oval shape.
soreness; fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN (soreness) and FATIGUE (fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and Blood pressure high. Concomitant products included CLORAZEPATE DIPOTASSIUM (CLORAZEPATE) for Anxiety, TRIAMTERENE for Blood pressure high, CHOLESTYRAMINE and COLESTYRAMINE (PREVALITE) for Diarrhea, DESIPRAMINE for Sleeplessness, PROPRANOLOL for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN (soreness) and FATIGUE (fatigue). At the time of the report, PAIN (soreness) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. for mRNA-1273(Moderna COVID-19 Vaccine) (Intramuscular) , the reporter did not provide causality assessment.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: concomitant medications added
Whole body rash, started about 7 hours after injection. Looked like mosquito bites on legs. By 24 hours after injection, rash had progressed to 1/2 to 3/4 circles with red margin. Many of the circles had merged into larger splotches. Covered abdomen and most of the legs completely. 100F fever starting about 30 hours after injection. Rash is slightly itchy, slightly painful when touched. Treated itchiness with benedryl. Treated fever with tylenol.
After one week severe stomach/abdominal pain. Thought was acid indigestion. Did not sleep all night.  Next afternoon middle back muscle pain.  Both still continuing  4 days later. Apsirin and Anicin not always effective.
temperature was up at 99 until April3 in the late evening.; Light headedness; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 30Mar2021 at 14:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included tinnitus, blood pressure high, vertigo. Concomitant medications included magnesium (MANUFACTURER UNKNOWN), (CALM) all from an unknown date for an unspecified indication. Patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 14:30, the patient experienced lightheaded as soon as she sat down for 15 min watch right after getting the vaccine before leaving the hospital. Arm was sore the same day and became more and more sore as the day progressed. On 02Apr2021, the patient experienced temperature was up at 99(UNSPECIFIED UNITS) until April3 in the late evening. Patient also stated that she felt lightheaded all day and until about 10:30pm the same day. She didn't eat much before getting vaccine and did drink coffee before-hand, carried heavy items afterwards so that might have something to do with it. The day after getting the vaccine, 31March she did not feel lightheaded but her arm was more-sore.  The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event lightheaded as soon as she sat down for 15 min watch right after getting the vaccine before leaving the hospital was recovered on 30Mar2021 at 22:30. Clinical outcome of arm was sore the same day and became more and more sore as the day progressed was recovered on 01Apr2021. Whereas, that of temperature was up at 99 recovered on 03Apr2021.  No follow-up attempts are needed. No further information is expected.
3 days p/receiving influenza immun, devel, sore throat, runny nose, cough (severe), off work a couple of days, felt sick for a couple of wks afterward;
experienced was a little of a sore arm.; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, mRNA, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 2021 as DOSE 1, SINGLE, received second dose via an unspecified route of administration on 2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced was a little of a sore arm on unspecified date 2021. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected. Batch/lot number not available for BNT162B2.
Developed black and blue over about 6 square inches of skin and that seemed a little unusual; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) intramuscular, in left arm for covid-19 immunisation; respiratory syncytial virus vaccine (RESPIRATORY SYNCYTIAL VIRUS VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "Blood pressure" (ongoing); "Cholesterol" (ongoing); "blood sugar" (ongoing). Concomitant medication(s) included: OLMESARTAN taken for blood pressure measurement (ongoing); CRESTOR taken for blood cholesterol (ongoing); TRAJENTA taken for blood glucose abnormal (ongoing); JARDIANCE taken for blood glucose abnormal (ongoing). Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer.), for Covid-19 Immunization. The following information was reported: VACCINATION SITE BRUISING (non-serious), outcome "unknown", described as "Developed black and blue over about 6 square inches of skin and that seemed a little unusual". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site bruising.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
I now have sciatica in the right side starting with the lower back.  The adverse reaction started with extreme pain down the right side, to the point that I couldn?t go longer than 2 hours before applying arthritis rub and taking OTC pain medication to be able to function,    Now my ride side is numb with some pain.  Since the vaccine I am unable to sit on any upholstered and are unable to sleep through the night without pain or numbness waking me up.
they moved me to the ER. Because I experienced the shortness of breath; pain modest site in gut bowled was so painful in the side of gut and the liver; pain modest site in gut bowled was so painful in the side of gut and the liver; experienced headache almost in after the modest was 15 minutes; I get the vaccine that day and the whole week I was feel like tired and not feeling well; I get the vaccine that day and the whole week I was feel like tired and not feeling well; This is a spontaneous report from a contactable consumer or other non-health care professional.   A 54-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8736; Expiration Date: 31Jul2021), via an unspecified route of administration, administered in Arm Left on 08May2021 as dose 1, single for COVID-19 immunization. Medical history included ongoing hypertension; ongoing blood cholesterol increased. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN (E.C.)) taken for blood cholesterol increased; simvastatin (SIMVASTATIN) taken for blood cholesterol increased; duloxetine hydrochloride (CYMBALTA) taken for blood cholesterol increased; buprenorphine hydrochloride (BELBUCA; Cinnamomum verum (CINNAMON); lansoprazole (ALBERTA); montelukast (MONTELUKAST); salbutamol sulfate (VENTOLIN ACCUHALER); cholecalciferol (VITAMINS D3). On an unspecified date, the patient experienced the shortness of breath, pain modest site in gut bowled was so painful in the side of gut and the liver, experienced headache almost in after the modest was 15 minutes, patient got the vaccine that day and the whole week patient was feel like tired and not feeling well. The consume was nostalgic on first dose. The outcome of the events was unknown.  "This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected."
No additional AEs were reported, no further information provided.; a patient received improperly stored vaccine; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions and allergies was provided.  On 19-OCT-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, rHa (PROQUAD) 0.5 milliliter, lot # U019287, expiration date 15-DEC-2022 (route and site of administration were not reported) for prophylaxis. The vaccine was stored in temperature 5.7 degrees  Fahrenheit for 6 minutes. There was no previous temperature excursion. It was not reported if the Digital Data Logger was involved. No adverse event was reported.
Rash all over the entire arm,red; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH ERYTHEMATOUS (Rash all over the entire arm,red) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Rash all over the entire arm,red). At the time of the report, RASH ERYTHEMATOUS (Rash all over the entire arm,red) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case concerns a male of unknown age who experienced a nonserious expected event of rash erythematous.  Event onset occurred with unknown latency after the first dose of mRNA-1273. Treatment included diphenhydramine. Event ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Reporter's Comments: This case concerns a male of unknown age who experienced a nonserious expected event of rash erythematous.  Event onset occurred with unknown latency after the first dose of mRNA-1273. Treatment included diphenhydramine. Event ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.